Interleukin-2 transcriptomic expression correlates with prolonged survival and with GNAS alterations in patients with advanced cancers
J. Ahmed, D. Nishizaki, Y. Fujiwara, P. DePietro, T.J. Jensen, T. McFall, S. Kato, R. Kurzrock · 2026
Read Interleukin-2 transcriptomic expression correlates with prolonged survival and with GNAS alterations in patients with advanced cancers by J. Ahmed, D. Nishizaki, Y. Fujiwara, P. DePietro, T.J. Jensen, T. McFall, S. Kato, R. Kurzrock (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13272506.txt.
Description
J. Ahmed and colleagues studied interleukin-2 gene activity in advanced cancers for a 2026 report. Interleukin-2 is a signal made by immune cells, and its level in tumors might affect how patients fare. The team also probed a link with changes in the GNAS gene.
Using data from 514 patients in a San Diego cohort and a much larger atlas cohort, they ranked tumor interleukin-2 levels against a reference group. Higher levels tracked with longer overall survival in both sets. Levels also rose alongside several immune checkpoint genes and GNAS changes. In lab made cells carrying a GNAS change, interleukin-2 output was higher, which supports a real biological link.
Catalog record
| CREATOR | J. Ahmed, D. Nishizaki, Y. Fujiwara, P. DePietro, T.J. Jensen, T. McFall, S. Kato, R. Kurzrock |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 70 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |